Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative Study of Vaccinated and Unvaccinated Hospitalised Patients: A Retrospective Population Study of 500 Hospitalised Patients with SARS-CoV-2 Infection in a Spanish Population of 220,000 Inhabitants.
Ruiz-Giardin JM, Rivilla M, Mesa N, Morales A, Rivas L, Izquierdo A, Escribá A, San Martín JV, Bernal-Bello D, Madroñal E, Farfán AI, Guerrero M, Calderón R, Duarte MA, Piedrabuena SI, Toledano-Macías M, Satué JÁ, Marrero J, de Ancos CL, Frutos B, Cristóbal R, Soria G, Ayala-Larrañaga I, Carpintero L, de Hita M, Lara C, Llerena ÁR, García V, Jiménez R, García V, Saiz-Lou EM, Prieto S, González-Pereira N, Lechuga LA, Tarancón J, Gonzalo S; FUENCOVID Group. Ruiz-Giardin JM, et al. Among authors: bernal bello d. Viruses. 2022 Oct 17;14(10):2284. doi: 10.3390/v14102284. Viruses. 2022. PMID: 36298839 Free PMC article.
Imatinib might constitute a treatment option for lung involvement in COVID-19.
Bernal-Bello D, Jaenes-Barrios B, Morales-Ortega A, Ruiz-Giardin JM, García-Bermúdez V, Frutos-Pérez B, Farfán-Sedano AI, de Ancos-Aracil C, Bermejo F, García-Gil M, Zapatero-Gaviria A, San Martín-López JV. Bernal-Bello D, et al. Autoimmun Rev. 2020 Jul;19(7):102565. doi: 10.1016/j.autrev.2020.102565. Epub 2020 May 3. Autoimmun Rev. 2020. PMID: 32376403 Free PMC article. No abstract available.
Imatinib for COVID-19: A case report.
Morales-Ortega A, Bernal-Bello D, Llarena-Barroso C, Frutos-Pérez B, Duarte-Millán MÁ, García de Viedma-García V, Farfán-Sedano AI, Canalejo-Castrillero E, Ruiz-Giardín JM, Ruiz-Ruiz J, San Martín-López JV. Morales-Ortega A, et al. Clin Immunol. 2020 Sep;218:108518. doi: 10.1016/j.clim.2020.108518. Epub 2020 Jun 27. Clin Immunol. 2020. PMID: 32599278 Free PMC article. No abstract available.
Early clinical experience with imatinib in COVID-19: Searching for a dual effect.
Morales-Ortega A, Rivas-Prado L, Frutos-Pérez B, Jaenes-Barrios B, Farfán-Sedano AI, García-Parra CJ, Hernández-Muniesa B, Duarte-Millán MÁ, Madroñal-Cerezo E, Ontañón-Nasarre A, Ruiz-Giardín JM, Bermejo F, García-Gil M, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D. Morales-Ortega A, et al. J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2021.02.002. Epub 2021 Feb 5. J Infect. 2021. PMID: 33549625 Free PMC article.
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients.
Morales-Ortega A, Farfán-Sedano AI, Izquierdo-Martínez A, Llarena-Barroso C, Jaenes-Barrios B, Mesa-Plaza N, Toledano-Macías M, Soria Fernández-Llamazares G, Molina-Esteban L, García de Tena J, Prieto-Menchero S, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D. Morales-Ortega A, et al. J Infect. 2022 Feb;84(2):248-288. doi: 10.1016/j.jinf.2021.08.034. Epub 2021 Aug 23. J Infect. 2022. PMID: 34437930 Free PMC article. No abstract available.
Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patients.
Duarte-Millán MA, Mesa-Plaza N, Guerrero-Santillán M, Morales-Ortega A, Bernal-Bello D, Farfán-Sedano AI, García de Viedma-García V, Velázquez-Ríos L, Frutos-Pérez B, De Ancos-Aracil CL, Soria Fernández-Llamazares G, Toledano-Macías M, Cristóbal-Bilbao R, Luquín-Ciuro N, Marrero-Francés J, Piedrabuena-García SI, Satué-Bartolomé JA, Gonzalo-Pascua S, Rivilla-Jiménez M, Carpintero-García L, Ayala-Larrañaga I, García-Bermúdez V, Lara-Montes C, Llerena-Riofrío ÁR, RIvas-Prado L, Walter S, Escriba-Barcena A, San Martín López JV, Ruíz-Giardín JM. Duarte-Millán MA, et al. J Med Virol. 2022 Apr;94(4):1540-1549. doi: 10.1002/jmv.27488. Epub 2021 Dec 7. J Med Virol. 2022. PMID: 34845754 Free PMC article.
Seven Epidemic Waves of COVID-19 in a Hospital in Madrid: Analysis of Severity and Associated Factors.
San Martín-López JV, Mesa N, Bernal-Bello D, Morales-Ortega A, Rivilla M, Guerrero M, Calderón R, Farfán AI, Rivas L, Soria G, Izquierdo A, Madroñal E, Duarte M, Piedrabuena S, Toledano-Macías M, Marrero J, de Ancos C, Frutos B, Cristóbal R, Velázquez L, Mora B, Cuenca P, Satué JÁ, Ayala-Larrañaga I, Carpintero L, Lara C, Llerena ÁR, García V, García de Viedma V, Prieto S, González-Pereira N, Bravo C, Mariño C, Lechuga LA, Tarancón J, Gonzalo S; FUENCOVID Group; Moreno S, Ruiz-Giardin JM. San Martín-López JV, et al. Among authors: bernal bello d. Viruses. 2023 Aug 30;15(9):1839. doi: 10.3390/v15091839. Viruses. 2023. PMID: 37766248 Free PMC article.
High doses of systemic corticosteroids in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. A cohort study.
Rueda-Camino JA, Bernal-Bello D, Canora-Lebrato J, Velázquez-Ríos L, García de Viedma-García V, Guerrero-Santillán M, Duarte-Millán MA, Cristóbal-Bilbao R, Zapatero-Gaviria A. Rueda-Camino JA, et al. Rev Clin Esp (Barc). 2017 Dec;217(9):504-509. doi: 10.1016/j.rce.2017.07.012. Epub 2017 Aug 31. Rev Clin Esp (Barc). 2017. PMID: 28865758 English, Spanish.
Imatinib in COVID-19: hope and caution.
Bernal-Bello D, Morales-Ortega A, Isabel Farfán-Sedano A, de Tena JG, Martín-López JVS. Bernal-Bello D, et al. Lancet Respir Med. 2021 Sep;9(9):938-939. doi: 10.1016/S2213-2600(21)00266-6. Epub 2021 Jun 18. Lancet Respir Med. 2021. PMID: 34147143 Free PMC article. No abstract available.
Baricitinib or imatinib in hospitalized COVID-19 patients: Results from COVINIB, an exploratory randomized clinical trial.
Morales-Ortega A, Farfán-Sedano AI, San Martín-López JV, Escribá-Bárcena A, Jaenes-Barrios B, Madroñal-Cerezo E, Llarena-Barroso C, Mesa-Plaza N, Frutos-Pérez B, Ruiz-Giardín JM, Duarte-Millán MÁ, Piedrabuena-García SI, Carpintero-García L, Canalejo-Castrillero E, Mora-Hernández B, García-Parra CJ, Magro-García HA, Algaba-García A, Hernández-Muniesa B, Nasarre-López B, Ontañón-Nasarre A, Domínguez-García MJ, Gómez-Santos D, Prieto-Menchero S, García de Tena J, Bermejo F, García-Gil M, Gonzalo-Pascua S, Bernal-Bello D; COVINIB Study Group investigators. Morales-Ortega A, et al. Among authors: bernal bello d. J Med Virol. 2023 Feb;95(2):e28495. doi: 10.1002/jmv.28495. J Med Virol. 2023. PMID: 36639911 Clinical Trial.
42 results